Yes, cancer is on the rise globally. In 2022, there were an estimated 20 million new cancer cases worldwide, and that number is projected to reach over 35 million by 2050, a 77% increase. But the full picture is more nuanced than that headline figure suggests. More people are getting cancer, yet more people are surviving it than ever before, and some of the increase reflects better detection rather than a true surge in disease.
The Global Numbers
The World Health Organization reported 20 million new cancer cases and 9.7 million cancer deaths in 2022. The projected jump to 35 million cases by 2050 is driven by several overlapping forces: population growth, aging populations, and changing lifestyle patterns across the developing world.
Wealthier nations currently bear the largest absolute burden. In 2022, countries with very high human development saw roughly 9.3 million cases, compared to about 812,000 in the lowest-income countries. The age-adjusted rate in highly developed countries was 285.7 per 100,000, more than double the 110.6 per 100,000 in low-development countries. But the gap is narrowing fast. Low-income countries are expected to see a 142% increase in new cases by 2050, and medium-income countries a 99% increase. Cancer mortality in those countries is projected to nearly double, partly because treatment infrastructure hasn’t kept pace with the rising burden.
Cancer Is Increasing in Younger Adults
One of the more alarming trends is the rise of cancer in people under 50. A comprehensive NIH analysis of U.S. cancer data from 2010 through 2019 found that 14 types of cancer increased in incidence among younger adults during that decade. The largest jump in absolute numbers was in female breast cancer, with roughly 4,800 additional cases in 2019 compared to what 2010 rates would have predicted. Colorectal cancer followed with 2,100 extra cases, then kidney (1,800), uterine (1,200), and pancreatic cancers (500).
Colorectal cancer in particular has become a bellwether for this shift. Incidence is climbing by 3% per year in adults aged 20 to 49, with Hispanic adults seeing the steepest rise at 4% per year. Black, White, Asian American, and Native populations are all affected as well. This trend is one reason screening recommendations for colorectal cancer were lowered from age 50 to 45 in recent years.
Researchers don’t yet have a single explanation for why younger people are developing more cancers. The leading hypotheses point to changes in diet, rising obesity rates, sedentary lifestyles, and environmental exposures that have shifted over the past few decades. These are factors that affect people from childhood onward, potentially setting the stage for cancer earlier in life.
Obesity and Lifestyle as Driving Forces
Being overweight or obese is associated with a higher risk of developing 13 types of cancer, and those 13 types account for 40% of all cancers diagnosed in the United States each year. That’s a staggering proportion. The cancers on that list include some of the most common: breast, colorectal, kidney, uterine, and pancreatic, which are also the ones rising fastest in younger adults.
It’s worth noting that this 40% figure refers to the share of cancer types linked to excess weight, not a claim that obesity directly caused 40% of all cases. Still, the overlap between obesity-related cancers and the cancers increasing most in younger populations is hard to ignore. Global obesity rates have roughly tripled since 1975, and the generations now entering middle age grew up in an environment with more processed food, more sedentary habits, and higher average body weight than any previous generation.
Better Detection Complicates the Picture
Not all of the increase in cancer diagnoses reflects a true rise in disease. Screening programs for breast, prostate, cervical, and colorectal cancers catch tumors that might never have caused symptoms, especially slow-growing ones. When screening becomes more widespread or guidelines change, reported incidence can spike even if the underlying biology hasn’t shifted. Prostate cancer is a classic example: widespread PSA testing in the 1990s led to a dramatic jump in diagnoses, many of which were low-risk cancers that would never have been life-threatening.
This doesn’t mean screening is misleading. Catching cancer before it spreads is the single biggest factor in survival. But it does mean that rising incidence numbers need to be interpreted alongside mortality data to understand whether cancer is truly becoming more common or simply being found more often.
More Diagnoses, but Far Better Survival
Here’s the counterweight to the rising incidence numbers: cancer survival has improved dramatically. The overall five-year survival rate for all cancers combined in the United States has reached 70% for people diagnosed between 2015 and 2021. In the mid-1970s, that figure was just 50%. Seven in ten people now survive at least five years after diagnosis.
The gains have been especially striking for cancers that were once considered near-certain death sentences. Five-year survival for myeloma, a blood cancer, has climbed from 32% to 62% since the mid-1990s. Liver cancer survival went from 7% to 22%. Lung cancer, long one of the deadliest diagnoses, rose from 15% to 28%. For cancers that have already spread to distant parts of the body, survival has doubled overall, going from 17% to 35%.
In the U.S., the cancer death rate has fallen 34% since its peak in 1991, translating to roughly 4.5 million deaths averted. So while more people are being diagnosed with cancer, a smaller proportion of them are dying from it. The gap between incidence (going up) and mortality (going down) reflects real progress in treatment, earlier detection, and prevention efforts like reduced smoking rates.
What’s Driving the Rise, Region by Region
The forces behind rising cancer rates differ depending on where you look. In high-income countries, the increase is largely tied to aging populations, obesity, alcohol use, and the expansion of screening. These countries also have the resources to treat cancer effectively, which is why mortality has been declining even as diagnoses increase.
In low- and middle-income countries, the picture is grimmer. Rates are climbing due to a combination of factors: adoption of Western dietary and lifestyle habits, urbanization, rising tobacco use, and infections like HPV and hepatitis that cause cervical and liver cancers. At the same time, these countries often lack the oncology infrastructure, diagnostic tools, and trained specialists needed to treat patients effectively. The result is that cancer mortality in these regions is projected to nearly double by 2050.
This disparity means the global cancer burden is shifting. While wealthier nations will see the largest absolute increase in cases (an additional 4.8 million by 2050), the proportional increase will hit the poorest countries hardest, straining health systems that are already stretched thin.
The Short Answer
Cancer is genuinely on the rise, both in total numbers and in ways that can’t be explained by detection alone. The increase in younger adults is real and concerning. Obesity, dietary shifts, and lifestyle changes are plausible contributors that affect billions of people worldwide. At the same time, surviving cancer has never been more likely than it is today, and death rates in countries with strong healthcare systems continue to fall. The challenge ahead is less about whether cancer is increasing and more about ensuring that the progress in treatment and prevention reaches the parts of the world where the burden is growing fastest.